Status:
UNKNOWN
Amiodarone Usage After Ischemic Ventricular Tachycardia Ablation
Lead Sponsor:
Yuksek Ihtisas Hospital
Conditions:
Ischemic Cardiomyopathy
Ventricular Tachycardia
Eligibility:
All Genders
18+ years
Brief Summary
Ventricular Tachycardia ablation in ischemic cardiomyopathy patients is required procedure in cases when anti-arrhythmic drugs failed. The concern is if adjunctive continuation amiodarone after ablati...
Detailed Description
Ischemic cardiomyopathy patients have implantable cardioverter defibrillators (ICD) to prevent arrhythmic deaths. Ventricular tachycardia (VT) events with frequent ICD interventions in ischemic cardio...
Eligibility Criteria
Inclusion
- Ischemic cardiomyopathy patients applied with frequent ICD interventionor electrical storms and having ejection fraction below 50%. Frequent ICD defined as more than 1 ICD intervention within month. Electrical storm defined as more than 2 ICD intervention within one day.
Exclusion
- Patients with cardiomyopathies other than ischemic etiology
Key Trial Info
Start Date :
January 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2018
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03244748
Start Date
January 1 2016
End Date
March 1 2018
Last Update
August 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Turkiye Yuksek Ihtisas Training and Research Hospital
Ankara, Turkey (Türkiye), 06590